# EDGAR Filing Document

**Accession Number:** 0001739174
**File Stem:** 0001213900-26-015681
**Filing Date:** 2026-2
**Character Count:** 2330
**Document Hash:** 02bb2d6eb72d4ebf3970d723d99bfc00
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-015681.hdr.sgml**: 20260421

**ACCESSION NUMBER**: 0001213900-26-015681

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BiomX Inc.
- **CENTRAL INDEX KEY:** 0001739174
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 823364020
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 850 NEW BURTON ROAD
- **STREET 2:** SUITE 201
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19904
- **BUSINESS PHONE:** 972 545610935

**MAIL ADDRESS:**
- **STREET 1:** 850 NEW BURTON ROAD
- **STREET 2:** SUITE 201
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19904

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Chardan Healthcare Acquisition Corp.
- **DATE OF NAME CHANGE:** 20180430

**BIOMX INC.**

708 Quince Orchard Rd, Suite 205

Gaithersburg, MD 20878

February 12, 2026

*<u>VIA EDGAR</u>*

Securities and Exchange Commission

Division of Corporation Finance<br> Office of Life Sciences<br> Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | BiomX Inc.<br> Registration Statement on Form S-3<br> Filed on February 9, 2026<br> File No. 333-293308 (the "***Registration Statement***")<br> Request for Acceleration |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the "***Commission***") under the Securities Act of 1933, as amended, BiomX Inc. hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 5:00 p.m., Eastern Time, on February 13, 2026, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick Werner, Esq. at (212) 659-4974.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **BIOMX Inc.** | **BIOMX Inc.** |
| By: | */s/ Jonathan Solomon* |
|  | Jonathan Solomon |
|  | Chief Executive Officer |

---

cc: Rick A. Werner, Esq., Haynes and Boone, LLP